Simcere Pharmaceutical launches open-market share buyback of up to RMB 1 billion

• Simcere launched an open-market share buyback worth up to RMB 1 billion, starting Aug. 21.
• Program runs until the next annual general meeting or an earlier cutoff under corporate rules, law, or shareholder action.
• Repurchases draw on a June 12 mandate allowing buybacks of up to 256,819,861 shares, equal to 10% of shares outstanding.
• Funding to come from internal resources.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Simcere Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260820-12293396), on August 20, 2026, and is solely responsible for the information contained therein.